US · Healthcare

Coeptis Therapeutics Inc (COEP)

Biotechnology

Coeptis Therapeutics Inc (COEP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for COEP

P/E ratio

25.00

Coeptis Therapeutics Inc (COEP) — FAQ

What is COEP's P/E ratio?

The price-to-earnings (P/E) ratio for Coeptis Therapeutics Inc (COEP) is 25.00 (data as of 2026-05-23).

Does Coeptis Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Coeptis Therapeutics Inc (COEP). Check the MyAverix Finance app for the latest dividend data.

What sector is Coeptis Therapeutics Inc in?

Coeptis Therapeutics Inc (COEP) is classified in the Healthcare sector (Biotechnology industry).

What exchange is COEP listed on?

COEP is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)